» Articles » PMID: 35923209

Comprehensive Mutations Analyses of (fat Mass and Obesity-associated Gene) and Their Effects on FTO's Substrate Binding Implicated in Obesity

Overview
Journal Front Nutr
Date 2022 Aug 4
PMID 35923209
Authors
Affiliations
Soon will be listed here.
Abstract

An excessive amount of fat deposition in the body leads to obesity which is a complex disease and poses a generic threat to human health. It increases the risk of various other diseases like diabetes, cardiovascular disease, and multiple types of cancer. Genomic studies have shown that the expression of the fat mass obesity () gene was highly altered and identified as one of the key biomarkers for obesity. This study has been undertaken to investigate the mutational profile of the gene and elucidates its effect on the protein structure and function. Harmful effects of various missense mutations were predicted using different independent tools and it was observed that all mutations were highly pathogenic. Molecular dynamics (MD) simulations were performed to study the structure and function of FTO protein upon different mutations and it was found that mutations decreased the structure stability and affected protein conformation. Furthermore, a protein residue network analysis suggested that the mutations affected the overall residues bonding and topology. Finally, molecular docking coupled with MD simulation suggested that mutations affected FTO substrate binding by changing the protein-ligand affinity. Hence, the results of this finding would help in an in-depth understanding of the molecular biology of the gene and its variants and lead to the development of effective therapeutics against associated diseases and disorders.

Citing Articles

rs17817449 Variant Increases the Risk of Severe Obesity in a Brazilian Cohort: A Case-Control Study.

Salum K, Assis I, Kopke U, Palhinha L, Abreu G, Gouvea L Diabetes Metab Syndr Obes. 2025; 18:283-303.

PMID: 39906696 PMC: 11792641. DOI: 10.2147/DMSO.S451401.


Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity.

Cui Y, Wei J, Fan H, Li W, Zhao L, Wilkinson E Proc Natl Acad Sci U S A. 2024; 121(51):e2407910121.

PMID: 39661064 PMC: 11665913. DOI: 10.1073/pnas.2407910121.


In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease.

Patnaik D, Jena A, Kerry R, Duttaroy A Lipids Health Dis. 2023; 22(1):17.

PMID: 36717943 PMC: 9885621. DOI: 10.1186/s12944-023-01782-7.

References
1.
Kumar R, Kumar R, Tanwar P, Deo S, Mathur S, Agarwal U . Structural and conformational changes induced by missense variants in the zinc finger domains of GATA3 involved in breast cancer. RSC Adv. 2022; 10(65):39640-39653. PMC: 9057444. DOI: 10.1039/d0ra07786k. View

2.
Lin Y, Ueda J, Yagyu K, Ishii H, Ueno M, Egawa N . Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer. 2013; 13:337. PMC: 3716552. DOI: 10.1186/1471-2407-13-337. View

3.
Koes D, Baumgartner M, Camacho C . Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model. 2013; 53(8):1893-904. PMC: 3726561. DOI: 10.1021/ci300604z. View

4.
Zhang Z, Zhou D, Lai Y, Liu Y, Tao X, Wang Q . Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Lett. 2012; 319(1):89-97. DOI: 10.1016/j.canlet.2011.12.033. View

5.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View